WHO PQ and ROW Audits
WHO PQ and ROW Audits Explained: Complete Guide to Global Inspection Readiness and Compliance
WHO PQ and ROW Audits Explained: Complete Guide to Global Inspection Readiness and Compliance Essential Guide to WHO PQ and Rest-of-World Audits for Pharma Inspection Readiness Introduction to WHO PQ and ROW Audits The World Health Organization (WHO) Prequalification (PQ) program is a critical mechanism for ensuring that medicines, vaccines, and diagnostics supplied to UN agencies meet stringent quality, safety, and efficacy standards. In addition, Rest-of-World (ROW) audits conducted by regulatory authorities outside the ICH regions—such as Africa, Latin America, and Southeast Asia—are increasingly significant for companies seeking global market access. These audits verify GMP compliance and adherence to local…
WHO PQ Inspections: Requirements, Process, and Key Documents
WHO PQ Inspections: Requirements, Process, and Key Documents WHO PQ Inspections: Requirements, Process, and Key Documents Ensuring compliance with global quality standards is crucial for pharmaceutical companies engaged in the international market. The World Health Organization (WHO) Prequalification (PQ) program focuses on assessing the quality, safety, and efficacy of medicines, thereby facilitating access to essential health services around the globe. This article serves as a comprehensive guide to understanding WHO PQ inspections, covering requirements, processes, and key documentation necessary for achieving compliance. Additionally, it provides insights specifically tailored for regulatory affairs, quality assurance, and compliance professionals in the United States,…
How to Prepare a Site for WHO Prequalification Inspection
How to Prepare a Site for WHO Prequalification Inspection How to Prepare a Site for WHO Prequalification Inspection The World Health Organization (WHO) Prequalification (PQ) inspections are integral for pharmaceutical manufacturers aiming to demonstrate compliance with international quality standards. These inspections not only validate good manufacturing practices but also facilitate access to global markets for medicines. This article serves as a comprehensive guide for regulatory affairs and quality assurance professionals on preparing a site for a WHO PQ inspection. Following these step-by-step preparations will enhance FDA inspection readiness consulting and ensure your site is primed for success. 1. Understanding WHO…
WHO TRS Guidelines Used During Inspections
WHO TRS Guidelines Used During Inspections WHO TRS Guidelines Used During Inspections Inspection readiness is a pivotal aspect of maintaining compliance and ensuring the quality of pharmaceutical products in the global market. The World Health Organization (WHO) has established a series of guidelines known as WHO Technical Report Series (TRS) that outline the standards for Good Manufacturing Practices (GMP) and quality inspections. This article will guide you through the process of preparing for inspections according to WHO TRS, focusing on the implications for FDA inspection readiness consulting. The following sections will provide a detailed, step-by-step tutorial to ensure your organization…
Common WHO PQ Audit Findings in Developing Countries
Common WHO PQ Audit Findings in Developing Countries Common WHO PQ Audit Findings in Developing Countries In the rapidly evolving landscape of global healthcare, ensuring compliance with international standards is paramount for pharmaceutical companies, particularly those engaged in WHO Prequalification (PQ) processes. WHO PQ audits are designed to evaluate manufacturing practices, quality assurance, and overall compliance with Good Manufacturing Practices (GMP). This article aims to guide professionals in the pharmaceutical sector through common findings during WHO PQ audits in developing countries and how to prepare for these inspections. Understanding WHO PQ and its Importance The WHO Prequalification Programme is essential…
Differences Between WHO, UNICEF, and Global Fund GMP Checks
Differences Between WHO, UNICEF, and Global Fund GMP Checks Understanding the Differences Between WHO, UNICEF, and Global Fund GMP Checks Good Manufacturing Practices (GMP) are essential for ensuring that pharmaceutical products are produced consistently and controlled to quality standards. Different organizations such as the World Health Organization (WHO), UNICEF, and the Global Fund conduct GMP checks to assure the quality and safety of medicines. This comprehensive tutorial provides a step-by-step overview of the differences between these checks, helping regulatory affairs, quality assurance, compliance professionals, and those preparing for inspections in the pharmaceutical space better understand the system. Whether you are…
Audit Trends and Readiness in ROW (Rest of World) Markets
Audit Trends and Readiness in ROW (Rest of World) Markets Audit Trends and Readiness in ROW (Rest of World) Markets In an evolving regulatory landscape, understanding the nuances of audit trends and readiness in Rest of World (ROW) markets is essential for companies engaged in the global supply chain. This comprehensive guide will provide regulatory affairs, compliance, and quality assurance professionals with a step-by-step approach to preparing for audits, particularly focusing on WHO Prequalification (PQ) audits and ROW inspections. As regulatory compliance becomes increasingly complex, staying informed about these trends is critical. Understanding the Framework of ROW Audits Audits are…
Preparing for Regulatory Audits in Africa, ASEAN, and GCC
Preparing for Regulatory Audits in Africa, ASEAN, and GCC Preparing for Regulatory Audits in Africa, ASEAN, and GCC In an ever-evolving regulatory landscape, organizations involved in pharmaceutical manufacturing, clinical trials, and drug distribution must prioritize compliance across various regions. This article details a step-by-step guide on preparing for regulatory audits in Africa, ASEAN, and the Gulf Cooperation Council (GCC) member states, with a focus on achieving compliance with international standards, including those set by the WHO Prequalification (PQ) program and other regional frameworks. Understanding the Regulatory Landscape The regulatory landscape in Africa, ASEAN, and the GCC presents unique challenges and…
PQS and Quality Manual Requirements for WHO Audits
PQS and Quality Manual Requirements for WHO Audits PQS and Quality Manual Requirements for WHO Audits Organizations involved in pharmaceutical manufacturing and distribution must comply with various regulations to ensure that their products are safe, effective, and of high quality. Among the essential regulatory frameworks is the World Health Organization (WHO) prequalification program, which aims to ensure that quality medicines are accessible to those who need them. This article will provide a step-by-step tutorial guide for understanding the PQS (Pharmaceutical Quality System) and the Quality Manual requirements for WHO audits, offering U.S.-based regulatory affairs, quality assurance, compliance, and inspection readiness…
How to Address CAPAs from WHO Inspections
How to Address CAPAs from WHO Inspections How to Address CAPAs from WHO Inspections Inspection readiness is a paramount concern for pharmaceutical companies engaged in global supply, particularly when facing audits from the World Health Organization (WHO) and other regulatory bodies. This article serves as a comprehensive step-by-step tutorial guide for addressing Corrective and Preventive Actions (CAPAs) identified during WHO inspections. By adhering to the outlined processes, regulatory affairs professionals can ensure compliance and maintain high-quality standards across their operations. Understanding WHO Inspections and CAPAs The WHO conducts inspections under its Prequalification (PQ) program to assess the quality and compliance…